Valeant Pharmaceutical International Inc. Changes Strategy; Is Now the Time to …
The Motley Fool Canada
The strategy for Valeant Pharmaceutical International Inc. (TSX: VRX)(NYSE: VRX) since its inception has been to acquire companies and integrate them into the overall ecosystem of the bigger corporation. However, after it failed to acquire Allergan, Inc.
Valeant Pharmaceuticals Intl Sees Significant Decline in Short Interest (VRX)sleekmoney
all 4 news articles >>
Source: pharmaceutical – Google News
Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd